Commonwealth Writers

Suzette Mayr wins the 2022 Scotiabank Giller Prize

Retrieved on: 
Tuesday, November 8, 2022
Honey, RCI, News, ReLit Awards, Foundation, Company, Writer, Dentistry, Fiction, Free-ranging dog, Graywolf Press, Book, Scotiabank, Freedom to Read Foundation, Giller Prize, Toronto Stock Exchange, Awareness, Amazon (company), Guadalajara International Book Fair, NYSE, AMZN, COVID-19, Partnership, Conference, Coach House Books, CBC, Coyote, New York Stock Exchange, Commonwealth Writers, TSX, Literacy, NASDAQ, IDG, CBC Radio One, Jury, Ferro-Grumley Award, Brotherhood of Sleeping Car Porters, Intention, American, World Trade Center Guadalajara, Writers Guild of Alberta, Hare, BNS, Radio, Prize, Graphic novel, Century, City, Random House of Canada, Canadian Broadcasting Corporation, Entertainment, Publishing, Wool, Pharmaceutical industry, Indigo, Widow, Monoceros

TORONTO, Nov. 7, 2022 /CNW/ - Suzette Mayr has been named the winner of the 2022 Scotiabank Giller Prize for her novel, The Sleeping Car Porter, published by Coach House Books, taking home $100,000 courtesy of Scotiabank.

Key Points: 
  • TORONTO, Nov. 7, 2022 /CNW/ - Suzette Mayr has been named the winner of the 2022 Scotiabank Giller Prize for her novel, The Sleeping Car Porter, published by Coach House Books, taking home $100,000 courtesy of Scotiabank.
  • "Suzette Mayr's magnificent and powerful work of fiction inspired this year's jury to select her as the 2022 Scotiabank Giller Prize winner and cements her reputation as a world-class writer.
  • "Congratulations to Suzette Mayr for winning the 2022 Scotiabank Giller Prize.
  • Scotiabank is proud that our partnership with the Scotiabank Giller Prize, which began in 2005, has helped raise the profile of Canada's top literary talent at home and abroad.

Dr. David Sinclair Joins Levels as Advisor

Retrieved on: 
Tuesday, October 12, 2021
Medical Devices, Health, Technology, Diabetes, Fitness & Nutrition, Software, Lazarus, Harvard Medical School, NAD, Book, Memory, Biotechnology, National, Biology, CGM, Diabetes, Time, Department of Genetics, University of Cambridge, SpaceX, Cancer, TIME, Research, Chromatin, Commonwealth Writers, Molecular genetics, Technology, CR, Neurodegeneration, Prediabetes, Calorie, Google, Sleep, University, Resveratrol, Awareness, Leadership, Diet, Food, Multimedia, SIRT1, Regeneration, Respiration (physiology), Mammal, Exercise, Stanford University, Sirtuin, Department, Doctor of Philosophy, Health, Longevity, Mitochondrion, Microdeletion syndrome, Learning, Partnership, Science, Biomarker, Pharmaceutical industry, News, Medical device

Levels , the first biosensor system to give real-time feedback on nutrition and lifestyle, today announced that leading longevity scientist Dr. David Sinclair has joined the company as a Levels Advisor .

Key Points: 
  • Levels , the first biosensor system to give real-time feedback on nutrition and lifestyle, today announced that leading longevity scientist Dr. David Sinclair has joined the company as a Levels Advisor .
  • Dr. Sinclair has been at the forefront of the latest discoveries in understanding why we age and how to slow its effects.
  • Dr. Sinclair joins an unprecedented group of thought leaders, clinicians, and researchers in metabolic health, and his expertise will help to drive awareness to the metabolic health crisis through content development and research in partnership with the Levels team.
  • View the full release here: https://www.businesswire.com/news/home/20211012005133/en/
    Dr. David Sinclair Joins Levels as Advisor (Photo: Business Wire)
    Im excited to work with Levels Health to empower people with the tools to optimize their bodies and help achieve longer healthspans and lifespans, says Dr. Sinclair.